Pipeline of Tourette Syndrome Market Reviewed for H2 2015

Mar 22, 2016, 06:00 ET from RnR Market Research

PUNE, India, March 22, 2016 /PRNewswire/ --

RnRMarketResearch.com adds "Tourette Syndrome - Pipeline Review, H2 2015" to its store. The report provides an overview of the Tourette Syndrome's therapeutic pipeline with comprehensive information on the therapeutic development for Tourette Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Tourette Syndrome and special features on late-stage and discontinued projects.

Complete report on H2 2015 pipeline review of Tourette Syndrome with 22 market data tables and 11 figures, spread across 72 pages is available at http://www.rnrmarketresearch.com/tourette-syndrome-pipeline-review-h2-2015-market-report.html .

The report also reviews key players involved in the therapeutic development for Tourette Syndrome and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies discussed in this Tourette Syndrome Pipeline Review, H2 2015 report include AstraZeneca Plc, Catalyst Pharmaceutical Partners, Inc., Edison Pharmaceuticals, Inc., Neurocrine Biosciences, Inc., Psyadon Pharmaceuticals, Inc., Reviva pharmaceuticals Inc., Synchroneuron Inc. and Teva Pharmaceutical Industries Limited. Drug profiles discussed in this research report includes acamprosate calcium SR, AZD-5213, CPP-115, dutetrabenazine ER, ecopipam hydrochloride, RP-5063, valbenazine, vatiquinone and vigabatrin.

Order a purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=419682 .

Scope of this report: The report provides a snapshot of the global therapeutic landscape of Tourette Syndrome and reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities with key players involved in the therapeutics development for Tourette Syndrome and enlists all their major and minor projects. The report summarizes all the dormant and discontinued pipeline projects, review of the Tourette Syndrome products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages, a detailed assessment of monotherapy and combination therapy pipeline projects, coverage of the Tourette Syndrome pipeline on the basis of target, MoA, route of administration and molecule type and latest news and deals relating related to pipeline products.

Another newly published market research report titled on Partial Seizure - Pipeline Review, H2 2015 provides comprehensive information on the therapeutic development for Partial Seizure, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Partial Seizure and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Partial Seizure Pipeline market research report of 95 pages is available at http://www.rnrmarketresearch.com/partial-seizure-pipeline-review-h2-2015-market-report.html .

Explore more reports on Neurology therapeutics.

About Us:   

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.


Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel:  +1-888-391-5441
sales@rnrmarketresearch.com

Connect with Us: 
G+ / Google Plus: https://plus.google.com/104156468549256253075/posts
Twitter: https://twitter.com/RnRMR
Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345


SOURCE RnR Market Research